Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000723635 | SCV000225840 | uncertain significance | not provided | 2015-01-23 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000194482 | SCV000249381 | uncertain significance | not specified | 2015-02-06 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000270534 | SCV000479356 | uncertain significance | Congenital cerebellar hypoplasia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000764831 | SCV000895987 | uncertain significance | Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000764831 | SCV001331412 | uncertain significance | Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Gene |
RCV000723635 | SCV001795514 | uncertain significance | not provided | 2024-10-15 | criteria provided, single submitter | clinical testing | Reported previously in the compound heterozygous state in a patient with autism spectrum disorder; however, no further clinical information was provided and the patient also harbored a variant in a different gene (PMID: 35668055); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 29117201, 35668055) |
Labcorp Genetics |
RCV000723635 | SCV002305237 | uncertain significance | not provided | 2022-05-15 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 634 of the VLDLR protein (p.Arg634His). This variant is present in population databases (rs35339834, gnomAD 0.2%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with VLDLR-related conditions. ClinVar contains an entry for this variant (Variation ID: 194212). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Not Available"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Prevention |
RCV003917617 | SCV004736580 | likely benign | VLDLR-related disorder | 2022-04-19 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |